Beta
Fexofenadine
medication Under reviewA second-generation antihistamine used to treat symptoms of seasonal allergic rhinitis and chronic idiopathic urticaria.
Research summary
Scientific evidence from meta-analyses and controlled trials confirms fexofenadine's efficacy in reducing symptoms of allergic rhinitis and urticaria compared to placebo, with a favorable safety profile showing low rates of sedation and no cardiovascular risks. Studies in healthy humans demonstrate no disruptive effects on cognitive or psychomotor functions even at high doses, supporting its use as a non-sedating option. Overall consensus highlights its tolerability and superiority over older antihistamines in avoiding drowsiness while providing rapid symptom relief.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Fexofenadine to your stack to report effects
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
Not specified in excerpt
201373Orig1s000 Medical Review
FDA Reviewers
No reports yet
Be the first to report this effect and help the community.
Add Fexofenadine to your stack to report effects
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
Not specified in excerpt
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Fexofenadine to your stack to report effects
Update meta-analysis on the efficacy and safety issues of fexofenadine hydrochloride in allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials
Not specified in excerpt
201373Orig1s000 Medical Review
FDA Reviewers
Research (3 studies)
Update meta-analysis on the efficacy and safety issues of fexofenadine hydrochloride in allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials
Not specified in excerpt
201373Orig1s000 Medical Review
FDA Reviewers
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
Not specified in excerpt
Community updates
No updates yet for this supplement.
Be the first to share your experience!